Esperovax, Inc. is a company headquartered in Plymouth, MI, that develops capsule vaccine. It was founded by David O'Hagan, Roger S. Newton and Savita Nikam. Robin A. Robinson is currently the CEO of the firm.\nThe company says this about itself: Esperovax was founded in 2019 to advance development of its Egress RD? oral mRNA platform, a transformative technology for delivering mRNA vaccines to the abundant population of immune cells in the gastrointestinal tract via a small oral capsule. The company's proprietary platform enables a broad suite of oral vaccines and therapeutics that are safe, elicit robust immunity, remain stable at room temperature and can be produced at markedly lower cost than traditional vaccines. Selected as a BLUE KNIGHT? company earlier this year, Esperovax has three pending patents. In 2020 the company was awarded a 2020 BARDA contract supporting the development of an oral mRNA CoV19 vaccine as part of BARDA DRIVe's Beyond the Needle program. The company's offices and laboratories are currently located in Plymouth, Michigan.

Part of University of Arkansas System, Board of Trustees of The University of Arkansas is a company headquartered in Fayetteville, AR, that owns and operates radio stations.

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

USAMRMC

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Volution Immuno Pharmaceuticals SA, part of Akari Therapeutics Plc, is a Swiss company located in Geneva that develops anti complement and anti inflammatory molecules as treatments for orphan conditions in the autoimmune and inflammatory diseases sectors. It was founded by Raymond Prudo-Chlebosz, who has been the CEO of the firm since 2008. Volution Immuno Pharmaceuticals SA was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million.

Zhejiang Meibaolong Biotechnology Co., Ltd., established on 2011-11-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Agricultural Science Research and Experimental Development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Sales of plastic products;Chemical product sales(No licensed chemical products);Instrument sales;Experimental analysis instrument sales;Drug testing equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Alberta Research Chemicals Inc provides knowledge based drug discovery services to major biotech, pharmaceutical and research organizations.

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Qingdao Chengen Medical Technology Co., Ltd., established on 2013-08-13, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;New material technology research and development;Synthetic Materials Sales;Manufacturing of plastic products;Sales of plastic products;Manufacturing of medical packaging materials;Manufacture of plastic crates and containers;Manufacturing of metal packaging containers and materials;Sales of metal packaging containers and materials;Arts and crafts and collectibles retail(Except for ivory and its products);Arts and crafts and collectibles wholesale(Except for ivory and its products);daily mask(non-medical)Production;daily mask(non-medical)Sales;Disinfectant sales(Free of Hazardous Chemicals);Professional cleaning,to clean,Disinfection service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Disinfectant production(Free of Hazardous Chemicals);Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in four clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer (India), locally advanced cervical cancer (GOG/NCI US study), head and neck cancer (CRUK study), and anal cancer (BrUOG). Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence.

Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Chengdu Zhengneng Biotechnology Co., Ltd., established on 2007-05-22, Business scope includes biological reagents,Research on biological products,Production,Sales;research in medical technology,Technology Transfer and Technology Consulting;Sales instrumentation,Equipment,laboratory equipment,Computer hardware and software and auxiliary equipment,Chemical Products(Does not contain dangerous goods);Engaged in foreign trade operations of import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).